All articles
TrendingAndrew ScottOscars 2027Best Actorprediction marketsawards season

Andrew Scott Best Actor Nomination Odds Reach 34% on No News

A 12pp move in 3 days with no public catalyst. Kalshi prices him at 30%, Polymarket at 38%, suggesting conviction without consensus.

July 3, 20265 min readJoseph Francia, Market Analyst
Where the market standsUpdated September 26, 2026
86%+52 pp since publishedvia Polymarket

Bottom line

A 12pp move in 3 days with no public catalyst. Kalshi prices him at 30%, Polymarket at 38%, suggesting conviction without consensus.

Market average
88% YES
Best listed price
88¢ · Kalshi
KalshiTrade YES at 88¢
Andrew Scott (actor)
Andrew Scott (actor)Wikipedia

Andrew Scott's Oscar Odds Just Jumped 12 Points, and Nobody Knows Why

Something is moving in the Best Actor nomination market for Andrew Scott, and no one can point to why. No trailer dropped. No festival slate was announced. No profile ran in a major outlet. No distributor leaked a release date. Over the past 72 hours, the Irish actor's implied probability of receiving a Best Actor nomination at the 2027 Oscars climbed from 23% to 34% across Kalshi and Polymarket. That 12-percentage-point jump happened in a complete informational vacuum.

A 12-point move in 3 days with zero cited news or competitor shifts means this repricing is driven entirely by speculative positioning, not information. That makes it either a leading indicator or a mispricing waiting to be corrected. In Oscar nomination markets, which tend to be reactive to festival premieres, trailer releases, and critic previews, a move of this magnitude without a news peg is statistically unusual. The market is telling us something. The question is whether it's right.

Prediction-market view

Live prices, venue by venue

Compare the latest YES price at each venue. Check market rules, liquidity, and fees before trading.

Current new-user offer · Kalshi

Get a $35 trading bonusCode PRED35

New users only. Eligibility restrictions and terms apply.

View current offer

Where Andrew Scott Now Sits in the Best Actor Race

At 34%, Andrew Scott is no longer a speculative longshot. He's being priced as a probable nominee. The Academy's Best Actor category has five slots. Any candidate trading above roughly 30% is being treated by the collective market as more likely than not to occupy one of those seats, particularly at this stage of the cycle when the field is still forming. Scott's period low of 17% makes the current price even more striking: a 17-percentage-point swing from trough to present, with most of that move concentrated in the last three days.

The platform-level spread offers additional texture. Kalshi prices Scott at 30%, while Polymarket has him at 38%. That 8-point gap is meaningful. It suggests the move is not uniform across trading populations. Polymarket's higher price could reflect a more aggressive speculative cohort, while Kalshi's lower figure may represent a more conservative crowd that hasn't fully bought into the upside thesis. When both platforms move in the same direction but at different speeds, it typically indicates the trade is gaining conviction without yet reaching consensus.

Without a public competitor list for this market, it's difficult to know exactly whom Scott is being measured against. But the absence of named frontrunners at this point in the awards cycle is itself informative. July is early. Major fall festival lineups from Venice, Telluride, and Toronto have not been announced. The Best Actor field is, by definition, incomplete. That makes any candidate trading above 30% in early July an unusually strong signal of market confidence.


The Informed Money Theory: Is a Major Andrew Scott Project About to Surface?

The most compelling explanation for a 12-point move without public news is that some segment of the market has access to private or semi-private information. This doesn't require insider trading in the legal sense. It could mean industry professionals who know the Venice or Toronto lineups before they're public, people close to a production who've seen rough cuts, or distributors who've begun quiet awards-season positioning. Andrew Scott has the profile to anchor exactly this kind of campaign. His work in All of Us Strangers (2023) earned him widespread critical praise and positioned him as a leading man capable of carrying prestige material.

The timing matters. Venice announces its competition lineup in late July. Toronto follows in August. If a major Scott-led film were selected for either festival's main competition, the current 34% price would look prescient rather than inflated. Oscar nomination markets are historically most volatile in the August-to-October window when festival premieres crystallize the field. A move in early July that anticipates a festival debut would be a textbook case of informed money front-running public information.

It's also possible the move reflects coordinated retail speculation rather than informed positioning. Prediction markets are susceptible to momentum trading, where a modest initial move attracts attention and follow-on buying. Without order book data, it's impossible to distinguish between a few large positions and many small ones.


The Case Against: Why 34% Might Be Too High

The strongest counter-argument is simple: Andrew Scott has no confirmed Oscar-contending film on the release calendar. As of July 3, 2026, there is no publicly announced project with a fall release window, no distributor campaign, and no festival selection. Pricing a 34% nomination probability for an actor without a known vehicle is aggressive by any historical standard. Most Best Actor nominees are associated with a specific film by this point in the cycle, or at least linked to a production with a known distributor and release strategy.

There is also the structural risk of early-cycle overpricing. Oscar markets in the summer months tend to assign higher probabilities to recognizable names because the field of competitors hasn't materialized. Once Venice and Toronto announce their lineups, new contenders flood the market. An actor who looked like a 34% probability in July can easily collapse to 15% by October as the field fills with performances that actually exist in the public domain. The 8-point spread between Kalshi and Polymarket reinforces this concern: disagreement at this level suggests the market hasn't settled on a price, which is a hallmark of speculative rather than informational trading.

If no film surfaces by the time festival lineups are announced, the current price will almost certainly correct downward. The market would have been pricing in anticipation that never materialized, and the correction could be swift.


What Happens Next

The resolution date for this market is January 21, 2027, when Oscar nominations are announced. Between now and then, the single most important variable is whether a specific Andrew Scott performance enters the awards conversation. The Venice Film Festival lineup announcement, expected in late July, is the nearest potential catalyst. If Scott appears in competition at Venice, the current 34% will likely look cheap. If he doesn't, and no alternative vehicle emerges by September, the market will face a reckoning.

For now, the 12-point move is a puzzle. It's either the market getting ahead of something real, or it's speculative froth in a thin summer market with no news to trade on. The next four weeks will determine which.

Join our Discord for breaking news alerts, driven by real-time movements in prediction markets.

The story so far: Oscar nominations for Best Actor?

8 updates · Aug 1 – Aug 21

2027 Oscar Best Actor Predictions Put Gosling at 57%Aug 21Ryan Gosling has a market-implied 57% chance of receiving a 2027 Best Actor nomination for Project Hail Mary.Turturro at 26% for Best Actor NominationAug 14A 12pp surge in 3 days prices a zero-time Oscar nominee as a real contender. Kalshi sits at 19% while Polymarket has him at 33%.Adam Driver at 27% for Best Actor Oscar NominationAug 12Driver's implied probability doubled in 72 hours across Kalshi and Polymarket, with no confirmed project attached to his name.